OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
Ryo Tamura, Kosuke Yoshihara, Takayuki Enomoto
Cancers (2022) Vol. 14, Iss. 9, pp. 2125-2125
Open Access | Times Cited: 14
Ryo Tamura, Kosuke Yoshihara, Takayuki Enomoto
Cancers (2022) Vol. 14, Iss. 9, pp. 2125-2125
Open Access | Times Cited: 14
Showing 14 citing articles:
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1845-1845
Open Access | Times Cited: 29
Valéria Tavares, Inês Soares Marques, Inês Guerra de Melo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1845-1845
Open Access | Times Cited: 29
Immunotherapy for Ovarian Cancer: Disappointing or Promising?
Mengqi Deng, Fan Tang, Xiangyu Chang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 454-466
Closed Access | Times Cited: 7
Mengqi Deng, Fan Tang, Xiangyu Chang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 2, pp. 454-466
Closed Access | Times Cited: 7
From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer
Zesi Liu, Chunli Jing, Fandou Kong
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Zesi Liu, Chunli Jing, Fandou Kong
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
STAT3 Signaling Pathway in Health and Disease
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Md Abdus Samad, Iftikhar Ahmad, A. M. Mahedi Hasan, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Trousseau Syndrome-Associated Acute Multifocal Cerebral Infarction: When Triple-Pathway Antithrombotic Therapy Overcomes Low Molecular Weight Heparin Resistance
Ke Wu, Lei Sheng
Cureus (2025)
Open Access
Ke Wu, Lei Sheng
Cureus (2025)
Open Access
Role of extracellular vesicles in cancer-specific interactions between tumour cells and the vasculature
Lata Adnani, Cristiana Spinelli, Nadim Tawil, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 196-213
Closed Access | Times Cited: 15
Lata Adnani, Cristiana Spinelli, Nadim Tawil, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 196-213
Closed Access | Times Cited: 15
CACNA1H restrains chemotherapy resistance in ovarian clear cell carcinoma cells by repressing autophagy
Huaijing Shi, Liang Zheng, Xinyan Jiang, et al.
Molecular Genetics and Genomics (2024) Vol. 299, Iss. 1
Closed Access | Times Cited: 1
Huaijing Shi, Liang Zheng, Xinyan Jiang, et al.
Molecular Genetics and Genomics (2024) Vol. 299, Iss. 1
Closed Access | Times Cited: 1
The Role of the Plasminogen Activator Inhibitor 1 (PAI1) in Ovarian Cancer: Mechanisms and Therapeutic Implications
Sneha Grace Mathews, Rajesh Krishna, M Lavanya, et al.
Global Medical Genetics (2024) Vol. 11, Iss. 04, pp. 358-365
Open Access | Times Cited: 1
Sneha Grace Mathews, Rajesh Krishna, M Lavanya, et al.
Global Medical Genetics (2024) Vol. 11, Iss. 04, pp. 358-365
Open Access | Times Cited: 1
The autopsy is not dead: ongoing relevance of the autopsy
Alexia Vignau, Clara Milikowski
Autopsy and Case Reports (2023) Vol. 13, pp. e2023425-e2023425
Open Access | Times Cited: 3
Alexia Vignau, Clara Milikowski
Autopsy and Case Reports (2023) Vol. 13, pp. e2023425-e2023425
Open Access | Times Cited: 3
Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma
Xiaoshi Liu, Huaiwu Lu, Ying Zhou, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11385-11395
Open Access | Times Cited: 2
Xiaoshi Liu, Huaiwu Lu, Ying Zhou, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11385-11395
Open Access | Times Cited: 2
Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study
Tingwei Liu, Yueqing Gao, Shuangdi Li, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
Tingwei Liu, Yueqing Gao, Shuangdi Li, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
Pathologic complete response to immune checkpoint inhibitor in a stage IIIB ovarian clear cell carcinoma patient with POLE mutation resistant to platinum-based chemotherapy: a case report
Shuzhan Li, Jiali Zhang, Weijiao Du, et al.
Gland Surgery (2022) Vol. 11, Iss. 9, pp. 1562-1567
Open Access | Times Cited: 1
Shuzhan Li, Jiali Zhang, Weijiao Du, et al.
Gland Surgery (2022) Vol. 11, Iss. 9, pp. 1562-1567
Open Access | Times Cited: 1
Ovarian clear cell cancer associated with Trousseau syndrome: A case report and literature review
Yilin You, Xing Chen, Yi Jiang, et al.
Medicine (2022) Vol. 101, Iss. 47, pp. e32106-e32106
Open Access | Times Cited: 1
Yilin You, Xing Chen, Yi Jiang, et al.
Medicine (2022) Vol. 101, Iss. 47, pp. e32106-e32106
Open Access | Times Cited: 1
Ovarian cancer – where are we today?
Irina Bălescu, Nicoale Bacalbasa, Iulian Brezean, et al.
Romanian Journal of Medical Practice (2022) Vol. 17, Iss. 3, pp. 125-127
Open Access
Irina Bălescu, Nicoale Bacalbasa, Iulian Brezean, et al.
Romanian Journal of Medical Practice (2022) Vol. 17, Iss. 3, pp. 125-127
Open Access
